Table 4.
Cognitive, EQ-5D QoL and blood tests: effect of the multi-domain intervention programme within and between groups.
| Variable | IG | CG | Group-time interaction | ||||||
|---|---|---|---|---|---|---|---|---|---|
| N | Baseline | 24 weeks | P | N | Baseline | 24 weeks | P | P | |
| Total RBANS | 76 | 51.63 ± 9.71 | 51.07 ± 10.37 | .219 | 72 | 50.04 ± 9.44 | 49.12 ± 9.63 | .056 | .238 |
| Immediate memory | 77 | 51.83 ± 9.23 | 50.22 ± 10.27 | .055 | 71 | 50.46 ± 9.30 | 49.77 ± 9.84 | .429 | .785 |
| Visuospatial/constructional | 76 | 51.47 ± 10.03 | 50.7 ± 11.33 | .454 | 71 | 50.18 ± 8.99 | 49.27 ± 8.45 | .337 | .391 |
| Language | 76 | 50.8 ± 9.44 | 51.08 ± 10.29 | .759 | 72 | 49.87 ± 9.85 | 48.78 ± 9.73 | .198 | .164 |
| Attention | 77 | 51.06 ± 9.86 | 50.97 ± 10.04 | .957 | 72 | 50.29 ± 9.65 | 48.98 ± 9.99 | .008* | .206 |
| Delayed memory | 76 | 51.03 ± 10.16 | 50.38 ± 10.57 | .365 | 72 | 50.31 ± 8.95 | 49.11 ± 10.27 | .246 | .462 |
| Total cholesterol (mg/dL) | 39 | 170.28 ± 47.41 | 176.72 ± 42.05 | .107 | 42 | 177.1 ± 40.20 | 179.57 ± 39.06 | .530 | .765 |
| HDL (mg/dL) | 39 | 53.74 ± 16.03 | 51.95 ± 16.43 | .839 | 43 | 55.58 ± 19.32 | 53.42 ± 13.89 | .980 | .801 |
| LDL (mg/dL) | 35 | 96.89 ± 40.87 | 107.31 ± 34.91 | .013* | 40 | 98.1 ± 35.18 | 100.4 ± 33.72 | .562 | .644 |
| Triglycerides (mg/dL) | 37 | 122.08 ± 56.54 | 114.41 ± 53.04 | .369 | 42 | 130.17 ± 66.56 | 129.5 ± 92.72 | .341 | .358 |
| Glucose (mg/dL) | 38 | 108.95 ± 26.32 | 105.66 ± 19.18 | .749 | 43 | 121.02 ± 58.90 | 121.63 ± 55.55 | .776 | .347 |
| QoL VAS | 78 | 79.67 ± 17.75 | 80.37 ± 18.22 | .928 | 72 | 82.69 ± 16.00 | 74.43 ± 21.8 | .000* | .071 |
| QoL index | 78 | 0.83 ± 0.21 | 0.84 ± 0.24 | .075 | 72 | 0.85 ± 0.22 | 0.78 ± 0.29 | .013* | .157 |
Data presented in mean ± SD.
*P < 0.05.